English
简体中文
Total: £ 56.28
Published Date: 2025-05-28 | Pages: 98 | Tables: 97 | Pharma & Healthcare
The global market for Dry Eye Syndrome Drugs was valued at US$ 5876 million in the year 2024 and is projected to reach a revised size of US$ 7959 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. In this report, we mainly study the drugs and eye drops for dry eye.
The Dry Eye Syndrome market is driven by the rising prevalence of dry eye conditions globally, fueled by aging populations, increased screen time, and lifestyle-related factors. The widespread use of digital devices has significantly contributed to eye strain and reduced blink rates, leading to a surge in dry eye cases, especially among younger demographics. Additionally, growing awareness of ocular health and improved diagnosis through advanced diagnostic tools have increased patient identification and treatment rates. The introduction of innovative therapies, including anti-inflammatory eye drops, tear-stimulating drugs, and device-based treatments, is also expanding the market landscape.
Despite growing demand, the Dry Eye Syndrome market faces several challenges, including underdiagnosis, variable symptoms, and limited long-term treatment efficacy. Many patients remain undiagnosed due to the overlap of symptoms with other ocular conditions and the subjective nature of the disease. Current treatments often offer only temporary relief rather than a cure, leading to poor adherence and patient dissatisfaction. Moreover, the development of new therapies is hindered by the complex pathophysiology of the condition, which involves both aqueous and evaporative components. Addressing these challenges requires improved diagnostic criteria, personalized treatment approaches, and increased investment in research and clinical trials.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Syndrome Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Syndrome Drugs.
The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Syndrome Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
OmniVision Pharma
Rohto
Prestige Consumer Healthcare
LION
Kenvue (VISINE)
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other
Segment by Application
Hospitals
Clinics
Homecare
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Eye Syndrome Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dry Eye Syndrome Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dry Eye Syndrome Drugs Market Perspective (2020-2031)
2.2 Global Dry Eye Syndrome Drugs Growth Trends by Region
2.2.1 Global Dry Eye Syndrome Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dry Eye Syndrome Drugs Historic Market Size by Region (2020-2025)
2.2.3 Dry Eye Syndrome Drugs Forecasted Market Size by Region (2026-2031)
2.3 Dry Eye Syndrome Drugs Market Dynamics
2.3.1 Dry Eye Syndrome Drugs Industry Trends
2.3.2 Dry Eye Syndrome Drugs Market Drivers
2.3.3 Dry Eye Syndrome Drugs Market Challenges
2.3.4 Dry Eye Syndrome Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dry Eye Syndrome Drugs Players by Revenue
3.1.1 Global Top Dry Eye Syndrome Drugs Players by Revenue (2020-2025)
3.1.2 Global Dry Eye Syndrome Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top Dry Eye Syndrome Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dry Eye Syndrome Drugs Revenue
3.4 Global Dry Eye Syndrome Drugs Market Concentration Ratio
3.4.1 Global Dry Eye Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dry Eye Syndrome Drugs Revenue in 2024
3.5 Global Key Players of Dry Eye Syndrome Drugs Head office and Area Served
3.6 Global Key Players of Dry Eye Syndrome Drugs, Product and Application
3.7 Global Key Players of Dry Eye Syndrome Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dry Eye Syndrome Drugs Breakdown Data by Type
4.1 Global Dry Eye Syndrome Drugs Historic Market Size by Type (2020-2025)
4.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2026-2031)
5 Dry Eye Syndrome Drugs Breakdown Data by Application
5.1 Global Dry Eye Syndrome Drugs Historic Market Size by Application (2020-2025)
5.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dry Eye Syndrome Drugs Market Size (2020-2031)
6.2 North America Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
6.4 North America Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dry Eye Syndrome Drugs Market Size (2020-2031)
7.2 Europe Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
7.4 Europe Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dry Eye Syndrome Drugs Market Size (2020-2031)
8.2 Asia-Pacific Dry Eye Syndrome Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dry Eye Syndrome Drugs Market Size (2020-2031)
9.2 Latin America Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
9.4 Latin America Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dry Eye Syndrome Drugs Market Size (2020-2031)
10.2 Middle East & Africa Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Dry Eye Syndrome Drugs Introduction
11.1.4 AbbVie Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Alcon
11.2.1 Alcon Company Details
11.2.2 Alcon Business Overview
11.2.3 Alcon Dry Eye Syndrome Drugs Introduction
11.2.4 Alcon Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.2.5 Alcon Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Dry Eye Syndrome Drugs Introduction
11.3.4 Novartis Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Santen Pharma
11.4.1 Santen Pharma Company Details
11.4.2 Santen Pharma Business Overview
11.4.3 Santen Pharma Dry Eye Syndrome Drugs Introduction
11.4.4 Santen Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.4.5 Santen Pharma Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Dry Eye Syndrome Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Bausch & Lomb
11.6.1 Bausch & Lomb Company Details
11.6.2 Bausch & Lomb Business Overview
11.6.3 Bausch & Lomb Dry Eye Syndrome Drugs Introduction
11.6.4 Bausch & Lomb Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.6.5 Bausch & Lomb Recent Development
11.7 Thea pharmaceuticals
11.7.1 Thea pharmaceuticals Company Details
11.7.2 Thea pharmaceuticals Business Overview
11.7.3 Thea pharmaceuticals Dry Eye Syndrome Drugs Introduction
11.7.4 Thea pharmaceuticals Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.7.5 Thea pharmaceuticals Recent Development
11.8 URSAPHARM
11.8.1 URSAPHARM Company Details
11.8.2 URSAPHARM Business Overview
11.8.3 URSAPHARM Dry Eye Syndrome Drugs Introduction
11.8.4 URSAPHARM Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.8.5 URSAPHARM Recent Development
11.9 SIMILASAN
11.9.1 SIMILASAN Company Details
11.9.2 SIMILASAN Business Overview
11.9.3 SIMILASAN Dry Eye Syndrome Drugs Introduction
11.9.4 SIMILASAN Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.9.5 SIMILASAN Recent Development
11.10 Akorn
11.10.1 Akorn Company Details
11.10.2 Akorn Business Overview
11.10.3 Akorn Dry Eye Syndrome Drugs Introduction
11.10.4 Akorn Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.10.5 Akorn Recent Development
11.11 United Laboratories
11.11.1 United Laboratories Company Details
11.11.2 United Laboratories Business Overview
11.11.3 United Laboratories Dry Eye Syndrome Drugs Introduction
11.11.4 United Laboratories Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.11.5 United Laboratories Recent Development
11.12 Sun Pharmaceutical
11.12.1 Sun Pharmaceutical Company Details
11.12.2 Sun Pharmaceutical Business Overview
11.12.3 Sun Pharmaceutical Dry Eye Syndrome Drugs Introduction
11.12.4 Sun Pharmaceutical Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.12.5 Sun Pharmaceutical Recent Development
11.13 Jianfeng Group
11.13.1 Jianfeng Group Company Details
11.13.2 Jianfeng Group Business Overview
11.13.3 Jianfeng Group Dry Eye Syndrome Drugs Introduction
11.13.4 Jianfeng Group Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.13.5 Jianfeng Group Recent Development
11.14 OmniVision Pharma
11.14.1 OmniVision Pharma Company Details
11.14.2 OmniVision Pharma Business Overview
11.14.3 OmniVision Pharma Dry Eye Syndrome Drugs Introduction
11.14.4 OmniVision Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.14.5 OmniVision Pharma Recent Development
11.15 Rohto
11.15.1 Rohto Company Details
11.15.2 Rohto Business Overview
11.15.3 Rohto Dry Eye Syndrome Drugs Introduction
11.15.4 Rohto Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.15.5 Rohto Recent Development
11.16 Prestige Consumer Healthcare
11.16.1 Prestige Consumer Healthcare Company Details
11.16.2 Prestige Consumer Healthcare Business Overview
11.16.3 Prestige Consumer Healthcare Dry Eye Syndrome Drugs Introduction
11.16.4 Prestige Consumer Healthcare Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.16.5 Prestige Consumer Healthcare Recent Development
11.17 LION
11.17.1 LION Company Details
11.17.2 LION Business Overview
11.17.3 LION Dry Eye Syndrome Drugs Introduction
11.17.4 LION Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.17.5 LION Recent Development
11.18 Kenvue (VISINE)
11.18.1 Kenvue (VISINE) Company Details
11.18.2 Kenvue (VISINE) Business Overview
11.18.3 Kenvue (VISINE) Dry Eye Syndrome Drugs Introduction
11.18.4 Kenvue (VISINE) Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.18.5 Kenvue (VISINE) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Artificial Tears
Table 3. Key Players of Anti-inflammatory Drugs
Table 4. Key Players of Other
Table 5. Global Dry Eye Syndrome Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Dry Eye Syndrome Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Dry Eye Syndrome Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Dry Eye Syndrome Drugs Market Share by Region (2020-2025)
Table 9. Global Dry Eye Syndrome Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Dry Eye Syndrome Drugs Market Share by Region (2026-2031)
Table 11. Dry Eye Syndrome Drugs Market Trends
Table 12. Dry Eye Syndrome Drugs Market Drivers
Table 13. Dry Eye Syndrome Drugs Market Challenges
Table 14. Dry Eye Syndrome Drugs Market Restraints
Table 15. Global Dry Eye Syndrome Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Dry Eye Syndrome Drugs Market Share by Players (2020-2025)
Table 17. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome Drugs as of 2024)
Table 18. Ranking of Global Top Dry Eye Syndrome Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Dry Eye Syndrome Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Dry Eye Syndrome Drugs, Headquarters and Area Served
Table 21. Global Key Players of Dry Eye Syndrome Drugs, Product and Application
Table 22. Global Key Players of Dry Eye Syndrome Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dry Eye Syndrome Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Dry Eye Syndrome Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. AbbVie Company Details
Table 48. AbbVie Business Overview
Table 49. AbbVie Dry Eye Syndrome Drugs Product
Table 50. AbbVie Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 51. AbbVie Recent Development
Table 52. Alcon Company Details
Table 53. Alcon Business Overview
Table 54. Alcon Dry Eye Syndrome Drugs Product
Table 55. Alcon Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 56. Alcon Recent Development
Table 57. Novartis Company Details
Table 58. Novartis Business Overview
Table 59. Novartis Dry Eye Syndrome Drugs Product
Table 60. Novartis Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Santen Pharma Company Details
Table 63. Santen Pharma Business Overview
Table 64. Santen Pharma Dry Eye Syndrome Drugs Product
Table 65. Santen Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 66. Santen Pharma Recent Development
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Dry Eye Syndrome Drugs Product
Table 70. Johnson & Johnson Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Bausch & Lomb Company Details
Table 73. Bausch & Lomb Business Overview
Table 74. Bausch & Lomb Dry Eye Syndrome Drugs Product
Table 75. Bausch & Lomb Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 76. Bausch & Lomb Recent Development
Table 77. Thea pharmaceuticals Company Details
Table 78. Thea pharmaceuticals Business Overview
Table 79. Thea pharmaceuticals Dry Eye Syndrome Drugs Product
Table 80. Thea pharmaceuticals Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 81. Thea pharmaceuticals Recent Development
Table 82. URSAPHARM Company Details
Table 83. URSAPHARM Business Overview
Table 84. URSAPHARM Dry Eye Syndrome Drugs Product
Table 85. URSAPHARM Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 86. URSAPHARM Recent Development
Table 87. SIMILASAN Company Details
Table 88. SIMILASAN Business Overview
Table 89. SIMILASAN Dry Eye Syndrome Drugs Product
Table 90. SIMILASAN Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 91. SIMILASAN Recent Development
Table 92. Akorn Company Details
Table 93. Akorn Business Overview
Table 94. Akorn Dry Eye Syndrome Drugs Product
Table 95. Akorn Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 96. Akorn Recent Development
Table 97. United Laboratories Company Details
Table 98. United Laboratories Business Overview
Table 99. United Laboratories Dry Eye Syndrome Drugs Product
Table 100. United Laboratories Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 101. United Laboratories Recent Development
Table 102. Sun Pharmaceutical Company Details
Table 103. Sun Pharmaceutical Business Overview
Table 104. Sun Pharmaceutical Dry Eye Syndrome Drugs Product
Table 105. Sun Pharmaceutical Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 106. Sun Pharmaceutical Recent Development
Table 107. Jianfeng Group Company Details
Table 108. Jianfeng Group Business Overview
Table 109. Jianfeng Group Dry Eye Syndrome Drugs Product
Table 110. Jianfeng Group Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 111. Jianfeng Group Recent Development
Table 112. OmniVision Pharma Company Details
Table 113. OmniVision Pharma Business Overview
Table 114. OmniVision Pharma Dry Eye Syndrome Drugs Product
Table 115. OmniVision Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 116. OmniVision Pharma Recent Development
Table 117. Rohto Company Details
Table 118. Rohto Business Overview
Table 119. Rohto Dry Eye Syndrome Drugs Product
Table 120. Rohto Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 121. Rohto Recent Development
Table 122. Prestige Consumer Healthcare Company Details
Table 123. Prestige Consumer Healthcare Business Overview
Table 124. Prestige Consumer Healthcare Dry Eye Syndrome Drugs Product
Table 125. Prestige Consumer Healthcare Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 126. Prestige Consumer Healthcare Recent Development
Table 127. LION Company Details
Table 128. LION Business Overview
Table 129. LION Dry Eye Syndrome Drugs Product
Table 130. LION Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 131. LION Recent Development
Table 132. Kenvue (VISINE) Company Details
Table 133. Kenvue (VISINE) Business Overview
Table 134. Kenvue (VISINE) Dry Eye Syndrome Drugs Product
Table 135. Kenvue (VISINE) Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
Table 136. Kenvue (VISINE) Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 140. Authors List of This Report
List of Figures
Figure 1. Dry Eye Syndrome Drugs Picture
Figure 2. Global Dry Eye Syndrome Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dry Eye Syndrome Drugs Market Share by Type: 2024 VS 2031
Figure 4. Artificial Tears Features
Figure 5. Anti-inflammatory Drugs Features
Figure 6. Other Features
Figure 7. Global Dry Eye Syndrome Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Dry Eye Syndrome Drugs Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Homecare Case Studies
Figure 12. Others Case Studies
Figure 13. Dry Eye Syndrome Drugs Report Years Considered
Figure 14. Global Dry Eye Syndrome Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Dry Eye Syndrome Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Dry Eye Syndrome Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Dry Eye Syndrome Drugs Market Share by Players in 2024
Figure 18. Global Dry Eye Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Dry Eye Syndrome Drugs Revenue in 2024
Figure 20. North America Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
Figure 22. United States Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
Figure 26. Germany Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Dry Eye Syndrome Drugs Market Share by Region (2020-2031)
Figure 34. China Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AbbVie Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 50. Alcon Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 52. Santen Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 54. Bausch & Lomb Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 55. Thea pharmaceuticals Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 56. URSAPHARM Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 57. SIMILASAN Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 58. Akorn Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 59. United Laboratories Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 60. Sun Pharmaceutical Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 61. Jianfeng Group Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 62. OmniVision Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 63. Rohto Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 64. Prestige Consumer Healthcare Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 65. LION Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 66. Kenvue (VISINE) Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
